Digestive Health Supplement for Gastrointestinal Discomfort Relief in Adults
Placebo
+ Active comparator
Supportive Care Study
Summary
Study start date: February 21, 2024
Actual date on which the first participant was enrolled.This clinical trial is focused on evaluating the effectiveness of a digestive health supplement called Nu Biome in relieving symptoms of gastrointestinal discomfort, specifically bloating, in healthy adults. The study involves both male and female participants aged 20 to 60 who regularly experience digestive issues. The trial aims to provide insights into how well this supplement works compared to a placebo, which in this study is Crystal Light Raspberry Lemonade. Understanding the supplement's effectiveness could lead to better management of digestive discomfort for those affected. Participants in the trial are randomly assigned to either the supplement group or the placebo group for four weeks. They will record their daily bowel habits and any abdominal discomfort. The study also includes questionnaires on digestion-related quality of life and perceptions of bloating, taken at the beginning, at two weeks, and at the end of the study. Waist measurements and digital photographs are also taken at these intervals to track any changes. The study does not mention any risks, focusing instead on observing potential improvements in digestive health.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 20 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location